COMPANY REGISTRATtON NUMBEtL' 53737 CHARrrY REGISTRATION NUMBER: 1113267 CERVICAL SPINE RFSEARCH soaEfY (EUROPEAN SEcfioN) Company Limited by Guarantee UNAUDTfED FINANCIAL ATEmEr5 31 DECEMBER 21713 LANGARD LIFFORD HALL LIMITED Accountants and Registered Auditors Iifford Hall Lifford tAne Kings Norton Birniingham B30 3JN
CERVICAL SPINE RESEARCH SOCIETY (EUROPEAN SECTION) COMPANY LIMITED BY GUARANTEE FINANCIAL STATEMENrs YEAR ENDED 31 DECEMBER 2023 Page Tntees, annual retM)rt (incorporating the directoes report) Independent exomineT'S Teport to the tntstses Statement of financial activities (including income and expettdire account) Statent of financial position Notes to the fInarjaI ststements The following page does not forni part of the financial statements Detailed ststement of financial activitie5 12
Page I CERVICAL SPINE RESEARCH SOCIETY IEUROPEAN SECTION) COMPANY LIMrrED BY GUARANTEE TRUSTEES, ANNUAL REPORT (INCORPORATING THE DIREcfoR'S REPOR YEAR ENDED 31 DECEMBER 2023 The trustees, who are akn the directors for the purposes of company law. present their report and the unaudited financiaI ststements of the charity for the year ended 31 Dernber 2023. Referen¢e and administrative deta118 Registered Charity name Ctrvical Spine Research &Iety (European Section) Charity registration number 1113267 Company registration number 53737(X) Principal office and reered Lifford Hall office Lifft)Td Lane Kings Norton B30 3JN The trnstees DT P Bancel DT A Combalia A Leonard Dr A l Geleway Independent examin K Schambers Lifford Hall Lifford tane Kings Norton B30 3JN Structurei governance and management The society was incorporaled as a company limited by guarantee on 13 February 2LK15 (company numtEr 537371]0) and obtained charitable stratus on 14 MaTch 2(KNS (charity number 1113267). The accounts are presented in Euros. Legal status The charity is a limited company by guardntee. In the event of the company being wound up, the Itability in resPt of the guarantee is limited to per Member.
Page 2 CERVICAL SPINE RESEARCH SOCIETY (EUROPEAN SECTION) TRUSTEES, ANNUAL REPORT IINCORPORATING THE DIRECTOR'S REPORT) (conliNxeAJ YEAR ENDED 31 DECEMBER 2(123 Objectives and actAvities The R9EuroPe strongly contributes to the academic evaluation OD cause and epidemiology of pathologist of the cervicaI spine and the developmenL feasibilxty. and effectiveness of treattnents of ¢ervical spine disordeTS. The R&F.uE0pe aims to provide a nelworking platform for scientists at their meettngs. active parlicipation in inteEnalional con8resses and dose engagement with their sisler societies. Achtevements and perfornianee The trustees aTe awaTe of the need to indemnty and monitrjr risk. As the charAty's work expands. a review of Tisks asswialed with the expansion will be implemented with a view to rnitigale any risks identified. For the year ended 2023, the annual general meeting vias held in stockhol Sweden Ist-2nd June 2013. The profit made from this conference was donated to the Sxiety. There were two instructional cadaver dissection courses held in Barcelona during 20ZS. The kniety plan5 two new additional educational 'hands on, cadavcric dIlon COUTses in 2024- Salzburg, Atria in Febnthry 2024 and Lyon. France in PteMr 2024. Financial review The charity's income increased during 21f23 to a41661 but expenditure totalling a45,751 the result is a net reduclion in reserves of £1,09) for the year. Reserves The tTUStee5 continue to aim to build up rerVeS to a level that will permit the sustained funding of projects. traintng fellowships and ongoing education by means of instructional and hands-on surgTcal courses. The appropriation of reserves and the level at which the trustees ¢on5ider thern necessary will be re-appraised on an annual basis and will be dependent UFon the projects to be undertaken. Small company provisions This report has been prepared in accordance with the provisions applicable to companie5 entitled to the small nies exemptson. The trus report was app ved on 22 May 2024 and signed on behalf of the board of Director
Page 3 CERVICAL SPINE RESEARCH SOCIETY IEUROPEAN SECTION) INDEPENDENf EXAMINER'S REPORT TO THE TRUSTEES OF CERVICAL SPINE RESEARCH SOCIEfY (EUROPEAN SECTION) YEAR ENDED 31 DECEMBER 2023 I report to the trustees on my examination of the ftnancial statements of Cenrical Spine Research Society {European &ction) ('the charity,) for the year ended 31 December 2023. Responsibilities and basis of report As the tTU5tees of the company (and also its directots for the PUTposes of company law) you are responsible for the preparation of the financiaI slatements in aCCordare with the requirnents of the Companie5 Act 2{m ('the 2(Kkn Arf). Having satisfied myself that the accounts of the cornpany are not required to audited under Part 16 of the 21kn Act and are eligible for independent examination, I report in re5F of my examination of the charity's accounts as carried out under section 145 of the IarItieS Act 2011 ('the 2011 Act.). In caTrying out my examination I have followed the Directions given by the Charity Commission under section 145(5)(b) of the 2011 ACL Independent exaznineT'g 5tatement- matter of concern identified I have completed my examItion. I confirm that no matter5 have come to my attention iti connection with the examination gtw me cause to Trt]ieve. accounting records were not kept in of the charity as rquired by Section 386 of the 2LX)6 Ac¢ or the financial statements do not accord with those records: OT the financlai statements do not comply with the accounting requirements of section 396 of the 2006 Act other than any requirement that the accounts give a'tsue and fair, view which is not a matter considered as part ofan independentexamination; or the financial statements have Eeen prepared in accordance with the methods and principles of the Statement of RecomDiended Practice for accounting and reporhng by charities applicable to charittes preparins their acci)unts in accordance with the Firwicial Repirttng Standard appIicable in the UK ad Republic of Ireland (FRS 102). I have no eoncerns and have acn)ss no other matters in connection with the examination to which attention should be drawn in thi8 report in order to enable a proFer understanding of the accounts to be reached. K S Chambers Independent Examiner Lifford Hall Lirford Lane Kings Norton Birmingham B30 3JN 22 May 2024
Page 4 CERVICAL SPINE RESEARCH SOCIETY (EUROPEAN SECTION) COMPANY LIMITED BY GUARANTEE STATEMEKf OF FINANCIAL AcnvrrIES (INCLUDING INCOME AND ExPENDURE AccouNr) YEAR ENDED 31 DECEMBER 2023 2022 Un$t[led nds Total funds Total rtd5 Note Income and endowments Voluntary income Total income 142,662 142,662 69217 142,662 142ffi2 69J17 Expenditure Expendiknre on charxtable activities Total expenditure 145,752 145,752 90,863 145.752 145,752 Net expenditure and net movement in funds (3iW) (3,0> {21.546) Reconciliation of fvnds TotaI funds brousht forward Total funds carried forward 211.458 211A58 2(BJ68 208J68 211.458 The statement of finala1 activities includes all gains and lo&ses recogni in the year. All income and expenditure derive from continuing activities. All movements aTe in Unrestricted Fund& The charity has no recognxsed gaxns or losses cthr than the results foT peTiod as set out above. All of the activities of the charity are classed as continuing. The notes on pages 6 to 11 forni part of these financial statement&
Pase 5 CERVICAL SPINE RESEARCH SOCIETY (EUROPEAN sEIoN) STATEMENT OF FINANCIAL POSTTION 31 DECEMBER 2023 2022 Fixed assets Tangible fixed assets 457 Current assels Debtots Cash at bank and in hand 219B91 210.n4 219PJ4 220A91 Creditors.. amounts falling due within one year Accwals and defeTred income li 9A9J Net current assets 211,001 Total assets less current liabilitie5 211,458 Net assets 2(BJ68 211,458 Funds of the clmrity Unrestricted tunds 2( 211,458 Total charity funds 14 211,458 For the year ending 31 Decemirr 2013 the charity was entitled to exemption from audit under section 477 of the Companies Att 2LX)6 relating to small companie Directors, TesponsTbilities.' The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476: The directors acknowledge theiT responsibilities for complying with the rquirements of the Att with respect to accowiting records and the preparation of financial statenwits. These fmancial statements have been prepared in accordance with the provisions applx¢able to companies bFct to the small compa ncial tements were ap d are stgned on oved by the iM)ard of tnkn and authoti5ed for i&sue on of the board by: 22Ma 24. Director The notes on pages 6 to 11 forni part of these financiat statement&
Pase 6 CERVICAL SPINE RESEARCH SOCIETY IEUROPEAN SEcfIoN) COMPANY LIMITED BY GUARANTEE NOTES TO THE FINANCIAL STATEMENTS YEAR ENDED 31 DECEMBER 2023 General inforniatson The charity is a public benait entity and a private company limited by guarantee. registered in England and Wales and a registered charity in England and Wales. The address of the registered office is Lifford Hall. Lifford Lane, Kings Norton, BIrni1ngha B30 3JN. Statement of compliance These financial sfatements have been prepared in Complian with FRS 102, The Financial Rep)rttng Standard applicable in the UK and the Republic of Ireland,, the Statement of Recomrnended Prarttce applicable to ciwities preparing their accounts in accordance with the Financial ReportÈng Standard applicable in the UK and Republic of Ireland IFRS 102) (Charities SORP IFRS 102)) and the Companies Act 21). Accounting policies Basig of preparation The fuwicial statements have been PTepared under the htoriCal convention and in accordance with the Statement of Recommended Practice 'Accounting and Reporting by arities. (SORP (FR5102)) and the CompatiiÉs Act 2011. The accounts have been PTepaTed and are Presented in Euros. Goins concern There are no material uncertainties al*)ut the charity's ability to continue. Cash flow statement The trustees have taken advantsge of the exemption from including a cash flow statement in the financial statements on the grounds that the charity is smalL Judgements and key sources of e5tiryti0n uncertainty The preparation of the financial staternts requires management to make judgements. estimates and assumptions that aff&Yt the amounts reported. These Éstimates and Judgements are continually revÈewed and are based on experien and other factors, including expertations of future events that are FElieved to be reasonable under the circumstances. Foreign currencies Assets and liabilities in foreign currencies are translated into Euros at the rates of exchange rnling at the baIance sheet date. TransaciM)ns in foTeign CUTrencies are translaied into Eur05 at the Iate of exchange rnling at the date of transartion. Exchange differences are taken into account in arriving at the operattng profiL Fund aceountAng Unrestricied funds are available for use at the discretion of the trustees to further any of the charity's purposes. Designated funds are unrestsicted funds earnwked by the trustees for particular fuknre proiect OT commitment
Page 7 CERVICAL SPINE RESEARCH SOCIETY (EUROPEAN SECTION) COMPANY LIMrrED BY GUARANfEE NOTES TO THE FINANCIAL STATEMENfs l¢o•tiwed) YEAR ENDED 31 DECEMBER 2023 Accounting policies Fund a¢counting Restrirted funds are Subjected restrictions on their expenditure declared by the donor or thTOU8h the terms of an appeaL and fall into one of two su1ClasseS. restrÉcted income fund5 or endowment fuJ)ds. Incoming re80UTees All income i5 included in the statement of fnanCl activities when entitlernent has passed to the charity, it is probable that the economic nefits a5cIated with the transaction wiIl flow to the charity and the amount Can be reliably measu. The following specific poIicies are applied to partieular categories of incomv. - income froni donations OT grants is recognised when there is evidence of entitlement to the 8ifL elpt is probable and its amount can be measured te]iably. - income from contracls for the suppty of services is recognised with the delivery of the contracted service. This [5 classified as unrestricted funds tmIess there is a contractual requirement for it to be spent on a particular purpose and retrned if unspenL in wl)ich case it may be Tegarded as restricled. Resources expended Expenditure is recognised on an accruals basis a liability is incurred. Expenditure includes any VAT which cannot be fully recovered. and is classxfÉed under headings of the stratement of linanciai activities to which it relafes: _ expenditure on charitable activities includes all costs incurred by a charity Èn undertakin8 activities that furtheT its charitable aims for the knefit of its beneficiaries. including those Support costs and costs relating to the governance of the chazity apportioned to charitable activities. - other expenditure includes all expenditute that is neither TeIated to raising funds for the charity nor part 0£ its expendiiure on charitable activities. All costs are allocated to expenditure categories fle¢tin8 the use OE the resource. Direct costs attrbutsble to a single activty are allocated directly to that aciivity. Shared cosLs are apportio[d between the acttvities they contribute to on a reasonable, justifiable and consistent basis. Tangible a&8ets Tangible assets are initially recorded at cos¢ and sub5equentty stated at C05t less any accutnulated depTeciation and iEnpairment los. Any tsngible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsquent accumulated depreciation and subsequent accumulated Èmpairment losses. An increase in the carrying amount of an asset as a resuIt of a revaluatio is recosni5ed in other recwised gains and losses, unlegs it reverses a charge foT impairment that has previously eTh T&ognid as expendi within the stsiement of financial acttvities. decrease in the carrying amount of an asset as a reslllt of revaluation, is recogni in other recolsed gains and losses except to which it off*ts any previous revaluaiion 8ain. in which the loss is shown within other recognId gains and losses on the statement of financial activities.
Page 8 CERVICAL SPINE RESEARCH SOCIETY (EUROPEAN SEcfKoN) NOTES TO THE FINANCIAL sfATEMENfs (coNtiAwd) YL4R ENDED 31 DECEMBER 20ZI Ae¢ountlng polioes Depreciation Depreciation i5 cakulated so as to wxxte off the (t or valuation of an asseL less its residual value, over the usdul economic life of that asset as follows: Fquipment 20% reducing balan Impairnient of flxed assels review for indicators of impairment is caTTied out at each reporting date, with the recoveTable amount being estimated where such indicators exisL Where the carrying value exceeds the recoverable amount, the asset is itnpaired accordinsly. Prior impairments are also Teviewed for possible reversal at reFWtllig dale. For the purpos of impairment testin& when it is not p(lb1e to esttniate the recoverable amount of an Individual asseL an estimate is made of the recovernble arnount of the ca5h- generating unit to which the asset belongs. The cash%enerating unit is the smallest identifiable grollp of assets that includes the asset and generates cash infiows that largely independent of the cash infiows froln other or gTOUPS of assets. For tmpairmenl testing of gldwI]L the gcM)dwill acquired in a business cornbination is, from the acquisition da(e, alliKated to each of the cash-geneTaling units that are expected to benefit from the synergies of the combination, irresi)ective of whether other a&sets or liabitities of thecharity are assIed to those untts. Finanaal instrnments A financial asset or a financid ]iability is rwtsed only when enlity becomes a paty to the contrartual provisiorLS of the instTument. Basic financial instruments InitlY Tecognised at the amount re1vable or payable including any related transaction costs. unless the arrangement constitutes a financing transaction, where it Ts recognised at the present value of the futUTe payments discounted at a market Tate of Inte$t for a similar debt instrument. Llmited by guarantee The charity is a limÈted company by guarantee. In the event of the company beins wound up. the liability In respect of the guarantee is ]imited kn £1 Fer member.
Page 9 CERVICAL SPINE RESEARCH SOCIETY (EUROPEAN SECTION) COMPANY LIMrfED BY GUARANfEE NOTES TO THE FINANCIAL STATEMENfs (CO1a) YEAR ENDED 31 DECEMBER 2013 Voluntary income Unrestricied Total Funds Unrestrirted Total Funds Funds Funds 2022 Donations Donations and sponsorship Course swnsorship and delegate contributions 86sn 86571 46,916 46,916 56.1 56JfX 22.400 Other donations and lewies Bank interest 142,662 142.662 69J17 69,317 Expenditure on charAtable activities by fund type Unresttlcted Total Funds Unrestrictrd Total Funds Funds Funds 2022 Educational COUTSes SupportcosLs 106,454 39298 I(A54 39,¥)8 50.522 40J41 50522 40341 145.752 145.752 90 Expenditure on clwAtable aetivities by aclivity type Activitie5 undertaken directly Support Total funds Total fund costs 2022 Educational courses IffiAS1 145,752 Analysis of support costs Support costs Total 2011 Total 2022 Finance costs Accountancy & B¢)okkeeping Professional fees Depreciation cretarial expen 1,744 3?70 18.443 1,744 3J70 18,443 91 15,650 IA20 7,165 6J)15 114 15,725 15,6 40,439
Pase 10 CERVICAL SPINE RESEARCH SOCIETY IEUROPEAN SECTION) COMPANY LIMrrED BY GUARANTEE NOTES TO THE FINANCIAL STATEMENTS (coxtiAud) YEAR ENDED 31 DECEMBER 2023 Net expenditu Net expelldlTe i5 Stated after clwging/(credittng): Depreciation of tsngible fixed assets Foreign exchange difference5 114 1203 1,190 l(L Independent exaMItion fees 2022 Fees payable to the independent examiner for: Independent examination of the financial slateDients 16,196 11946 Jl. Trnstees and executive cOnnittee members The trustees and executive committee members htsve Teceived no remuneration during the year for tntstee duties. Expenses in respect of travel costs only in attendxng instructional courses as lecturers and meetings requirin8 presidential representation have been reimbursed to certain trusiees and executive commitlee members amountin8 to a6292 {2022: e13,754). Payments have iwi made to A L£onard of (2(Y21. t25,627) in respect of secretarial and adMinitiOn work carried OUL 11 Tanglble fjxed •&sets Equipment Cost At l January %)13 •nd 31 December XQ3 Depre¢iation At 15anuary 2023 a)arge for the year At 31 December 2023 782 92 874 Carrylng amount At 31 December 21Y23 365 At 31 December 2022 457
Pase 11 CERVICAL SPINE RESEARCH SOCIETY (EUROPEAN SECTION) COMPANY LIMTfED BY GUARAiwfEE NOTES TO THE FINANCIAL STATEMENfs I contrKNed) YEAR ENDED 31 DECEMBER 2023 13. Debtors 2022 Prepayments and accrued income 14. Analysis of charAtabIe funds Unrestricted funds At 31 Deeember At l january 2023 Income Expenditure General funds 211.458 141fA)2 (145,752) 208.368 At 31 DecemEEr 2022 At l ]anuary 21Y22 Income E%ndIture General funds Z33.tDI 69J17 (90,863) 211,458 15. Analysis of net assets between funds Unrestricted Total Funds Funds 2023 Tangible fixed assets Current assets Creditors less than l year Net assets 365 219W94 365 219,894 111,8911 208J68 208,368 Unrestricted Total Fund5 2022 Tanble fixed a&sets Current assets Creditors less than l year Net assets 457 220,491 (9,490) 211.458 457 220,491 (9,490) 211,458